{"entity":{"type":"insider","cik":"0001302443","url":"/insider/0001302443","json_url":"/insider/0001302443.json","name":"Winningham Rick E","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":48,"n_filings":26,"first":"2008-03-11","last":"2026-05-27","span_basis":"filed_date"},"name_variants":[{"name":"Winningham Rick E","source":"filing","n_filings":26,"first_seen":"2008-03-11","last_seen":"2026-05-27"}],"transactions":[{"id":6074775,"accession":"0001302443-26-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001302443-26-000008","line_url":"/filing/0001302443-26-000008#line-2","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2741.0,"shares_display":"2,741","price_per_share":241.57,"price_display":"241.57","price_state":"stated","total_value":662143.37,"total_display":"662,143.37","total_whole":"662,143","shares_owned_after":9567.0,"shares_owned_after_display":"9,567","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-22","filed_date":"2026-05-27","scope":"insider"},{"id":5191251,"accession":"0001302443-25-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001302443-25-000006","line_url":"/filing/0001302443-25-000006#line-1","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":180.8597,"price_display":"180.86","price_state":"stated","total_value":994728.35,"total_display":"994,728.35","total_whole":"994,728","shares_owned_after":8893.0,"shares_owned_after_display":"8,893","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-18","filed_date":"2025-11-20","scope":"insider"},{"id":8641039,"accession":"0001765581-23-000094","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001765581-23-000094","line_url":"/filing/0001765581-23-000094#line-2","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1241.0,"shares_display":"1,241","price_per_share":138.1584,"price_display":"138.16","price_state":"stated","total_value":171454.5744,"total_display":"171,454.57","total_whole":"171,455","shares_owned_after":10444.0,"shares_owned_after_display":"10,444","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-14","filed_date":"2023-08-15","scope":"insider"},{"id":6245046,"accession":"0001415889-22-012648","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-22-012648","line_url":"/filing/0001415889-22-012648#line-2","is_derivative":false,"issuer_cik":"0001302443","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001302443","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":11.19,"price_display":"11.19","price_state":"stated","total_value":559500.0,"total_display":"559,500.00","total_whole":"559,500","shares_owned_after":1350797.0,"shares_owned_after_display":"1,350,797","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-14","filed_date":"2022-12-16","scope":"insider"},{"id":6794197,"accession":"0001765581-22-000102","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001765581-22-000102","line_url":"/filing/0001765581-22-000102#line-2","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1089.0,"shares_display":"1,089","price_per_share":152.3226,"price_display":"152.32","price_state":"stated","total_value":165879.3114,"total_display":"165,879.31","total_whole":"165,879","shares_owned_after":8610.0,"shares_owned_after_display":"8,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-08","filed_date":"2022-08-09","scope":"insider"},{"id":5086461,"accession":"0001765581-21-000112","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001765581-21-000112","line_url":"/filing/0001765581-21-000112#line-1","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1306.0,"shares_display":"1,306","price_per_share":147.96,"price_display":"147.96","price_state":"stated","total_value":193235.76,"total_display":"193,235.76","total_whole":"193,236","shares_owned_after":7138.0,"shares_owned_after_display":"7,138","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-06","filed_date":"2021-08-10","scope":"insider"},{"id":2962301,"accession":"0001765581-20-000085","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001765581-20-000085","line_url":"/filing/0001765581-20-000085#line-2","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":931.0,"shares_display":"931","price_per_share":125.8699,"price_display":"125.87","price_state":"stated","total_value":117184.8769,"total_display":"117,184.88","total_whole":"117,185","shares_owned_after":6198.0,"shares_owned_after_display":"6,198","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-07","filed_date":"2020-08-10","scope":"insider"},{"id":8717744,"accession":"0001765581-19-000080","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001765581-19-000080","line_url":"/filing/0001765581-19-000080#line-2","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":726.0,"shares_display":"726","price_per_share":135.6504,"price_display":"135.65","price_state":"stated","total_value":98482.1904,"total_display":"98,482.19","total_whole":"98,482","shares_owned_after":4424.0,"shares_owned_after_display":"4,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-09","filed_date":"2019-08-12","scope":"insider"},{"id":6241041,"accession":"0001232524-18-000136","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001232524-18-000136","line_url":"/filing/0001232524-18-000136#line-7","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":660.0,"shares_display":"660","price_per_share":176.6108,"price_display":"176.61","price_state":"stated","total_value":116563.128,"total_display":"116,563.13","total_whole":"116,563","shares_owned_after":4950.0,"shares_owned_after_display":"4,950","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-10","filed_date":"2018-08-13","scope":"insider"},{"id":6241034,"accession":"0001232524-18-000136","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001232524-18-000136","line_url":"/filing/0001232524-18-000136","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15979.0,"shares_display":"15,979","price_per_share":176.1585592778021,"price_display":"176.16","price_state":"stated","total_value":2814837.6187,"total_display":"2,814,837.62","total_whole":"2,814,838","shares_owned_after":11094.0,"shares_owned_after_display":"11,094","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-09","filed_date":"2018-08-13","scope":"insider","n_lines":3},{"id":5307155,"accession":"0001179110-17-011428","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-17-011428","line_url":"/filing/0001179110-17-011428#line-1","is_derivative":false,"issuer_cik":"0001302443","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001302443","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":24.5,"price_display":"24.50","price_state":"stated","total_value":245000.0,"total_display":"245,000.00","total_whole":"245,000","shares_owned_after":866377.0,"shares_owned_after_display":"866,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-11","filed_date":"2017-08-11","scope":"insider"},{"id":4173963,"accession":"0001232524-17-000154","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001232524-17-000154","line_url":"/filing/0001232524-17-000154","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":662.0,"shares_display":"662","price_per_share":142.368415407855,"price_display":"142.37","price_state":"stated","total_value":94247.891,"total_display":"94,247.89","total_whole":"94,248","shares_owned_after":11097.0,"shares_owned_after_display":"11,097","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-11","filed_date":"2017-08-14","scope":"insider","n_lines":2},{"id":4460899,"accession":"0001232524-17-000119","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001232524-17-000119","line_url":"/filing/0001232524-17-000119#line-1","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":150.0,"price_display":"150.00","price_state":"stated","total_value":750000.0,"total_display":"750,000.00","total_whole":"750,000","shares_owned_after":10391.0,"shares_owned_after_display":"10,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-01","filed_date":"2017-06-02","scope":"insider"},{"id":2218662,"accession":"0001232524-16-000355","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001232524-16-000355","line_url":"/filing/0001232524-16-000355#line-1","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":633.0,"shares_display":"633","price_per_share":136.45,"price_display":"136.45","price_state":"stated","total_value":86372.85,"total_display":"86,372.85","total_whole":"86,373","shares_owned_after":15391.0,"shares_owned_after_display":"15,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-15","filed_date":"2016-08-17","scope":"insider"},{"id":8772578,"accession":"0001179110-15-012246","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-012246","line_url":"/filing/0001179110-15-012246#line-2","is_derivative":false,"issuer_cik":"0001302443","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001302443","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16860.0,"shares_display":"16,860","price_per_share":12.13,"price_display":"12.13","price_state":"stated","total_value":204511.8,"total_display":"204,511.80","total_whole":"204,512","shares_owned_after":602056.0,"shares_owned_after_display":"602,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-17","filed_date":"2015-08-17","scope":"insider"},{"id":8772577,"accession":"0001179110-15-012246","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-15-012246","line_url":"/filing/0001179110-15-012246#line-1","is_derivative":false,"issuer_cik":"0001302443","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001302443","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":63140.0,"shares_display":"63,140","price_per_share":11.79,"price_display":"11.79","price_state":"stated","total_value":744420.6,"total_display":"744,420.60","total_whole":"744,421","shares_owned_after":583298.0,"shares_owned_after_display":"583,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-14","filed_date":"2015-08-17","scope":"insider"},{"id":8886313,"accession":"0001209191-15-065346","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-065346","line_url":"/filing/0001209191-15-065346","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":801.0,"shares_display":"801","price_per_share":179.99689138576778,"price_display":"180.00","price_state":"stated","total_value":144177.51,"total_display":"144,177.51","total_whole":"144,178","shares_owned_after":14663.0,"shares_owned_after_display":"14,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-10","filed_date":"2015-08-11","scope":"insider","n_lines":2},{"id":6621068,"accession":"0001232524-14-000116","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001232524-14-000116","line_url":"/filing/0001232524-14-000116#line-1","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1087.0,"shares_display":"1,087","price_per_share":133.15,"price_display":"133.15","price_state":"stated","total_value":144734.05,"total_display":"144,734.05","total_whole":"144,734","shares_owned_after":14150.0,"shares_owned_after_display":"14,150","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-12","filed_date":"2014-08-14","scope":"insider"},{"id":7083574,"accession":"0001232524-14-000038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001232524-14-000038","line_url":"/filing/0001232524-14-000038#line-1","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27500.0,"shares_display":"27,500","price_per_share":140.0,"price_display":"140.00","price_state":"stated","total_value":3850000.0,"total_display":"3,850,000.00","total_whole":"3,850,000","shares_owned_after":13587.0,"shares_owned_after_display":"13,587","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-17","filed_date":"2014-04-21","scope":"insider"},{"id":5353456,"accession":"0001179110-13-014199","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-13-014199","line_url":"/filing/0001179110-13-014199#line-1","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22353.0,"shares_display":"22,353","price_per_share":40.03,"price_display":"40.03","price_state":"stated","total_value":894790.59,"total_display":"894,790.59","total_whole":"894,791","shares_owned_after":690106.0,"shares_owned_after_display":"690,106","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-12","filed_date":"2013-09-13","scope":"insider"},{"id":5173949,"accession":"0001232524-13-000094","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001232524-13-000094","line_url":"/filing/0001232524-13-000094#line-1","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1070.0,"shares_display":"1,070","price_per_share":81.86,"price_display":"81.86","price_state":"stated","total_value":87590.2,"total_display":"87,590.20","total_whole":"87,590","shares_owned_after":41087.0,"shares_owned_after_display":"41,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-13","filed_date":"2013-08-14","scope":"insider"},{"id":4277154,"accession":"0001179110-13-007588","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-13-007588","line_url":"/filing/0001179110-13-007588","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":255532.0,"shares_display":"255,532","price_per_share":33.64419657811938,"price_display":"33.64","price_state":"stated","total_value":8597168.84,"total_display":"8,597,168.84","total_whole":"8,597,169","shares_owned_after":723128.0,"shares_owned_after_display":"723,128","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-30","filed_date":"2013-05-02","scope":"insider","n_lines":2},{"id":2678831,"accession":"0001179110-12-012532","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-12-012532","line_url":"/filing/0001179110-12-012532","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75749.0,"shares_display":"75,749","price_per_share":27.951599757092502,"price_display":"27.95","price_state":"stated","total_value":2117305.73,"total_display":"2,117,305.73","total_whole":"2,117,306","shares_owned_after":627458.0,"shares_owned_after_display":"627,458","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-03","filed_date":"2012-08-07","scope":"insider","n_lines":2},{"id":8923047,"accession":"0001179110-11-007894","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-11-007894","line_url":"/filing/0001179110-11-007894#line-2","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":73100.0,"shares_display":"73,100","price_per_share":26.28,"price_display":"26.28","price_state":"stated","total_value":1921068.0,"total_display":"1,921,068.00","total_whole":"1,921,068","shares_owned_after":485906.0,"shares_owned_after_display":"485,906","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-11","filed_date":"2011-05-12","scope":"insider"},{"id":8923045,"accession":"0001179110-11-007894","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-11-007894","line_url":"/filing/0001179110-11-007894#line-1","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54646.0,"shares_display":"54,646","price_per_share":26.41,"price_display":"26.41","price_state":"stated","total_value":1443200.86,"total_display":"1,443,200.86","total_whole":"1,443,201","shares_owned_after":559006.0,"shares_owned_after_display":"559,006","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-10","filed_date":"2011-05-12","scope":"insider"},{"id":9147079,"accession":"0001179110-11-004156","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-11-004156","line_url":"/filing/0001179110-11-004156#line-1","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63873.0,"shares_display":"63,873","price_per_share":22.53,"price_display":"22.53","price_state":"stated","total_value":1439058.69,"total_display":"1,439,058.69","total_whole":"1,439,059","shares_owned_after":613652.0,"shares_owned_after_display":"613,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-01","filed_date":"2011-03-03","scope":"insider"},{"id":9014063,"accession":"0001179110-11-003652","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001179110-11-003652","line_url":"/filing/0001179110-11-003652","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":67000.0,"shares_display":"67,000","price_per_share":23.045223880597014,"price_display":"23.05","price_state":"stated","total_value":1544030.0,"total_display":"1,544,030.00","total_whole":"1,544,030","shares_owned_after":677525.0,"shares_owned_after_display":"677,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-28","filed_date":"2011-02-28","scope":"insider","n_lines":2},{"id":9014060,"accession":"0001179110-11-003652","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-11-003652","line_url":"/filing/0001179110-11-003652","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92200.0,"shares_display":"92,200","price_per_share":22.456876355748374,"price_display":"22.46","price_state":"stated","total_value":2070524.0,"total_display":"2,070,524.00","total_whole":"2,070,524","shares_owned_after":684773.0,"shares_owned_after_display":"684,773","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-25","filed_date":"2011-02-28","scope":"insider","n_lines":2},{"id":9014057,"accession":"0001179110-11-003652","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-11-003652","line_url":"/filing/0001179110-11-003652#line-2","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":93100.0,"shares_display":"93,100","price_per_share":21.45,"price_display":"21.45","price_state":"stated","total_value":1996995.0,"total_display":"1,996,995.00","total_whole":"1,996,995","shares_owned_after":599123.0,"shares_owned_after_display":"599,123","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-24","filed_date":"2011-02-28","scope":"insider"},{"id":9147066,"accession":"0001179110-11-003305","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001179110-11-003305","line_url":"/filing/0001179110-11-003305#line-7","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":97600.0,"shares_display":"97,600","price_per_share":21.14,"price_display":"21.14","price_state":"stated","total_value":2063264.0,"total_display":"2,063,264.00","total_whole":"2,063,264","shares_owned_after":556273.0,"shares_owned_after_display":"556,273","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-23","filed_date":"2011-02-23","scope":"insider"},{"id":9147064,"accession":"0001179110-11-003305","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-11-003305","line_url":"/filing/0001179110-11-003305","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":168800.0,"shares_display":"168,800","price_per_share":21.473933649289098,"price_display":"21.47","price_state":"stated","total_value":3624800.0,"total_display":"3,624,800.00","total_whole":"3,624,800","shares_owned_after":521673.0,"shares_owned_after_display":"521,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-22","filed_date":"2011-02-23","scope":"insider","n_lines":2},{"id":3121103,"accession":"0001179110-08-005645","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001179110-08-005645","line_url":"/filing/0001179110-08-005645","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302443","owner_name":"Winningham Rick E","owner_display_name":"Winningham Rick E","owner_url":"/insider/0001302443","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":10.471049,"price_display":"10.47","price_state":"stated","total_value":209420.98,"total_display":"209,420.98","total_whole":"209,421","shares_owned_after":43118.0,"shares_owned_after_display":"43,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-11","filed_date":"2008-03-11","scope":"insider","n_lines":8}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":48,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":11,"open_market":true},{"code":"S","label":"Open-market sale","n":37,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":48},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001232524","name":"Jazz Pharmaceuticals plc","url":"/issuer/0001232524","role":"Director","n_filings":15,"first_seen":"2013-08-14","last_seen":"2026-05-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001583107","name":"Theravance Biopharma, Inc.","url":"/issuer/0001583107","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","n_filings":3,"first_seen":"2015-08-17","last_seen":"2022-12-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001080014","name":"THERAVANCE INC","url":"/issuer/0001080014","role":"Director, Officer (Chief Executive Officer)","n_filings":8,"first_seen":"2008-03-11","last_seen":"2013-09-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001302443","retrieved_at":"2026-08-27T15:19:53+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}